A comprehensive view of Liver / Kidney / Bladder Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna and Generation Bio partner to develop non-viral genetic medicines using Generation Bio's proprietary stealth cell-targeted lipid nanoparticle delivery system; Moderna to develop two immune cell programs and two liver programs
Published: March 23, 2023 by Moderna Inc.
Novartis enters into global licensing agreement with Teijin Pharma to develop, manufacture, commercialize an investigational preclinical small molecule candidate for proteinuric kidney diseases; Teijin receives US$30M upfront in deal worth up to US$200M
Published: March 09, 2023 by Marketline - Deals
AstraZeneca backs new hyperkalemia public awareness video series from the National Kidney Foundation; NKF reports about 26 million people worldwide have experienced heart failure and are living with high potassium levels in their blood
Published: March 06, 2023 by FiercePharma
Integrated kidney care provider Somatus and UnitedHealthcare expand value-based kidney care agreement to five new states; deal to provide service to kidney patients in Connecticut, Illinois, Massachusetts, New Jersey, Rhode Island
Published: February 22, 2023 by PR Newswire
AstraZeneca’s Imfinzi durvalumab plus Imjudo tremelimumab approved in the EU for patients with advanced liver and non-small cell lung cancers; about 87,000 Europeans were diagnosed with liver cancer in 2020
Published: February 22, 2023 by AstraZeneca AB

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count